avtr101
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 23, 2022 (NCT06788236)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06788236 | Phase 2 | May 23, 2022 | Ajou University, Aventi Biotechnology Inc., Seoul National University, University of Ulsan |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ajou University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Aventi Biotechnology Inc. | For profit | 1 | 1 | 1 | 2022 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2022 |
4 organizations
Page 1 / 1